Effect of WF10 (TCDO) on HbA1c Values in Diabetic Foot Ulcer Patients

Diabetic Foot Ulcer (DFU) Clinical Trial

Official title:
Effect of WF10 (TCDO) on HbA1c Values in Diabetic Foot Ulcer Patients

Status Completed

Clinical Trial Summary

Study in adult Diabetes Mellitus patients with diabetic foot ulcers and elevated HbA1c who will receive standard wound treatment in combination with adjuvant therapy WF10 to compare the change of HbA1c levels at baseline and after treatment.

Clinical Trial Description

Single-center, Prospective Open-labelled One Group Pretest Posttest Pilot Study ;

Study Design

Related Conditions & MeSH terms

Diabetic Foot
Diabetic Foot Ulcer (DFU)
Foot Ulcer
Ulcer
Uncontrolled Diabetes With Foot Ulcer

Clinical Trial Details

NCT number	NCT04372355
Study type	Interventional
Source	Srinakharinwirot University
Contact
Status	Completed
Phase	Phase 2
Start date	June 19, 2019
Completion date	June 19, 2020

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04277598` - A Study to Evaluate Safety and Efficacy of APO-2 at Three Different Doses in Patients With Diabetic Foot Ulcer	Phase 1/Phase 2
Not yet recruiting	`NCT06449638` - Modified Platform Trial Assessing Multiple CAMPs and SOC vs SOC Alone in the Treatment of Hard-to-Heal DFUs	N/A
Terminated	`NCT05438251` - Exploring the Effect of Fespixon Cream for the Treatment of Diabetic Foot Ulcers (TEXAS 3A, 3B)	Phase 4
Completed	`NCT01912092` - Askina Calgitrol Paste Diabetic Foot Ulcers	N/A